Literature DB >> 18049899

Tumour necrosis factor alpha in segmental colitis associated with diverticula.

Enzo Ierardi1, Gianmichele Meucci, Cesare Hassan, Angelo Zullo, Gianni Imperiali, Vincenzo De Francesco, Carmine Panella, Sergio Morini, Giorgio Minoli.   

Abstract

The pathogenesis of segmental colitis associated with diverticula (SCAD) is unclear, but tumour necrosis factor alpha (TNF-alpha) has been shown to play a pivotal role in the pathogenesis of inflammatory bowel diseases. The aim of this study was to assess TNF-alpha levels in patients with SCAD. In a post hoc analysis of a prospective multicenter study, tissue samples from 13 patients diagnosed with SCAD were subjected to histological analyses. The severity of the inflammation was assessed by means of a histological score and histomorphometry (number of inflammatory cells/mm2). Immunohistochemical staining with an antibody against TNF-alpha was performed on all biopsies and the degree of staining expressed as the percentage of positive stromal cells/1000 counted (TNF-alpha score). Matched patients with irritable bowel syndrome (IBS) were used as controls. Over-expression of TNF-alpha was found in all SCAD patients (38.6 +/- 10.4%), and it was associated with a high histological score (2.5 +/- 0.5) and neutrophil cell count (16.3 +/- 3/mm2). These values were distinctly higher than those found in the IBS controls. Our data suggest that TNF-alpha activity is involved in SCAD pathogenesis, similarly to what occurs in Crohn's disease and ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049899     DOI: 10.1007/s10620-007-0086-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly.

Authors:  M A Peppercorn
Journal:  Am J Gastroenterol       Date:  1992-05       Impact factor: 10.864

2.  A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.

Authors:  S E Plevy; C J Landers; J Prehn; N M Carramanzana; R L Deem; D Shealy; S R Targan
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

3.  Crohn's-like reaction in diverticular disease.

Authors:  A Gledhill; M F Dixon
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

4.  Helicobacter heilmannii gastritis: a histological and immunohistochemical trait.

Authors:  E Ierardi; R A Monno; A Gentile; R Francavilla; O Burattini; S Marangi; L Pollice; A Francavilla
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

5.  Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.

Authors:  B Berner; D Akça; T Jung; G A Muller; M A Reuss-Borst
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

6.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

7.  Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.

Authors:  J M Reimund; C Wittersheim; S Dumont; C D Muller; J S Kenney; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

8.  Segmental colitis associated with diverticula: a 7-year follow-up study.

Authors:  G Imperiali; M M Terpin; G Meucci; A Ferrara; G Minoli
Journal:  Endoscopy       Date:  2006-04-12       Impact factor: 10.093

9.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

10.  Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.

Authors:  C Hassan; E Ierardi; O Burattini; V De Francesco; A Zullo; G Stoppino; C Panella; S Morini
Journal:  Dig Liver Dis       Date:  2007-07-25       Impact factor: 4.088

View more
  8 in total

Review 1.  Segmental colitis associated with diverticulosis: complication of diverticular disease or autonomous entity?

Authors:  Antonio Tursi
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

Review 2.  Considerations and Changes in the Evaluation, Management, and Outcomes in the Management of Diverticular Disease: The Diagnosis, Pathology, and Treatment of Diverticular Colitis.

Authors:  Robert J Kucejko; Juan L Poggio
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

3.  A case of diverticular colitis with lesions resembling ulcerative colitis and correlation of tumor necrosis factor-alpha staining with clinical manifestations.

Authors:  Yoshinori Torii; Yoshiaki Katano; Junji Yoshino; Kazuo Inui; Takao Wakabayasi; Takashi Kobayashi; Toshihito Kosaka
Journal:  Clin J Gastroenterol       Date:  2015-12

4.  Effects of sevoflurane on NF-кB and TNF-α expression in renal ischemia-reperfusion diabetic rats.

Authors:  Yu Zhang; Fang Hu; Jianghua Wen; Xiaohong Wei; Yingjuan Zeng; Ying Sun; Shunkui Luo; Liao Sun
Journal:  Inflamm Res       Date:  2017-07-06       Impact factor: 4.575

Review 5.  Features and management of colonic diverticular disease.

Authors:  Jason Hemming; Martin Floch
Journal:  Curr Gastroenterol Rep       Date:  2010-10

Review 6.  Segmental colitis associated with diverticulosis: is it the coexistence of colonic diverticulosis and inflammatory bowel disease?

Authors:  John Schembri; John Bonello; Dimitrios K Christodoulou; Konstantinos H Katsanos; Pierre Ellul
Journal:  Ann Gastroenterol       Date:  2017-01-31

Review 7.  Paradigm shift: the Copernican revolution in diverticular disease.

Authors:  Angelo Zullo; Luigi Gatta; Roberto Vassallo; Vincenzo De Francesco; Raffaele Manta; Fabio Monica; Giulia Fiorini; Dino Vaira
Journal:  Ann Gastroenterol       Date:  2019-08-02

8.  Segmental colitis associated diverticulosis syndrome.

Authors:  Hugh J Freeman
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.